<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 .s4 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; }
 .s5 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 3pt; }
 .s6 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 5pt; }
 .s7 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 2pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 1; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: d1 2; }
 #l2> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l3 {padding-left: 0pt;counter-reset: d2 1; }
 #l3> li>*:first-child:before {counter-increment: d2; content: counter(d2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 #l5 {padding-left: 0pt;counter-reset: e1 5; }
 #l5> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: f1 2; }
 #l6> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l7 {padding-left: 0pt;counter-reset: f2 1; }
 #l7> li>*:first-child:before {counter-increment: f2; content: counter(f2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 #l8 {padding-left: 0pt;counter-reset: g1 14; }
 #l8> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 #l9 {padding-left: 0pt;counter-reset: h1 2; }
 #l9> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 #l10 {padding-left: 0pt;counter-reset: h2 1; }
 #l10> li>*:first-child:before {counter-increment: h2; content: counter(h2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: h2 0;  }
 #l11 {padding-left: 0pt;counter-reset: i1 1; }
 #l11> li>*:first-child:before {counter-increment: i1; content: counter(i1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l11> li:first-child>*:first-child:before {counter-increment: i1 0;  }
 #l12 {padding-left: 0pt;counter-reset: j1 1; }
 #l12> li>*:first-child:before {counter-increment: j1; content: counter(j1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l12> li:first-child>*:first-child:before {counter-increment: j1 0;  }
 li {display: block; }
 #l13 {padding-left: 0pt;counter-reset: k1 15; }
 #l13> li>*:first-child:before {counter-increment: k1; content: counter(k1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l13> li:first-child>*:first-child:before {counter-increment: k1 0;  }
</style><!-- Basic Meta Tags -->
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width,initial-scale=1" />

<!-- Page Title and Description -->
<meta name="description" content="Download and view the latest RGPV syllabus and timetable in PDF." />
<meta name="keywords" content="download, view, RGPV, syllabus, timetable, PDF" />

<!-- Robots Meta Tag -->
<meta name="robots" content="index, follow" />
<link rel="sitemap" href="/sitemap.xml" />

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:title" content="RGPV Syllabus and Timetable" />
<meta name="twitter:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Open Graph Meta Tags -->
<meta property="og:locale" content="en_IN" />
<meta property="og:type" content="website" />
<meta property="og:site_name" content="RGPV Syllabus and Timetable" />
<meta property="og:title" content="RGPV Syllabus and Timetable" />
<meta property="og:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Other Tags -->
<link rel="prefetch" />
<meta name="audience" content="all" />
<meta name="rating" content="general" />
<meta name="generator" content="site" />
<meta name="google" content="translate" />
<meta name="theme-color" content="#4DBA87" />
<meta name="geo.placename" content="India" />
<meta name="revisit-after" content="1 days" />
<meta property="fb:admins" content="100012765211323" />
<meta name="apple-mobile-web-app-capable" content="no" />

<!-- Apple Touch Icon -->
<meta name="apple-mobile-web-app-title" content="www.rgpv-syllabus-timetable.in" />
<meta name="apple-mobile-web-app-status-bar-style" content="default" />
<link rel="apple-touch-icon" href="/img/icons/apple-touch-icon-152x152.png" />

<!-- Favicon and Icons -->
<link rel="mask-icon" href="/img/icons/safari-pinned-tab.svg" color="#4DBA87" />
<link rel="icon" type="image/png" sizes="32x32" href="/img/icons/favicon-32x32.png" />
<link rel="icon" type="image/png" sizes="16x16" href="/img/icons/favicon-16x16.png" />
<meta name="msapplication-TileImage" content="/img/icons/msapplication-icon-144x144.png" />

<!-- Search Engine Tags -->
<meta name="search engines" content="Aeiwi, Alexa, AllTheWeb, AltaVista, AOL Netfind, Anzwers, Canada, DirectHit, EuroSeek, Excite, Overture, Go, Google, HotBot, InfoMak, Kanoodle, Lycos, MasterSite, National Directory, Northern Light, SearchIt, SimpleSearch, WebsMostLinked, WebTop, What-U-Seek, AOL, Yahoo, WebCrawler, Infoseek, Excite, Magellan, LookSmart, CNET, Googlebot" />

<!-- Pingback and OpenID -->
<link rel="pingback" href="https://www.rgpv-syllabus-timetable.in/" />
<link rel="openid.delegate" href="https://www.rgpv-syllabus-timetable.in/" />

<!-- Content Type -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><p class="s1" style="padding-top: 3pt;padding-left: 29pt;text-indent: 0pt;text-align: center;">INDUSTRIALPHARMACY(MIP)</p><p class="s2" style="padding-top: 1pt;padding-left: 31pt;text-indent: 0pt;line-height: 115%;text-align: center;">MODERN PHARMACEUTICAL ANALYTICAL TECHNIQUES (MIP 101T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: justify;">This subject deals with various advanced analytical instrumental techniques for identification, characterization and quantification of drugs. Instruments dealt are NMR, Mass spectrometer, IR, HPLC, GC etc.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">After completion of course student is able to know,</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">The analysis of various drugs in single and combination dosage forms</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Theoretical and practical skills of the instruments</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 12pt;text-indent: 0pt;text-align: center;">THEORY                              60 HOURS</p><ol id="l1"><li data-list-text="1."><p class="s3" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">	UV-Visible  spectroscopy:  <span class="p">Introduction,  Theory,  Laws, Instrumentation associated with UV-Visible spectroscopy, Choice of solvents and solvent effect and Applications of UV-Visible spectroscopy.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">IR spectroscopy<span class="p">: Theory, Modes of Molecular vibrations, Sample handling, Instrumentation of Dispersive and Fourier - Transform IR Spectrometer, Factors affecting vibrational frequencies and Applications of IR spectroscopy</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Spectroflourimetry: <span class="p">Theory of Fluorescence, Factors affecting fluorescence, Quenchers, Instrumentation and Applications of fluorescence spectrophotometer.</span></p><p class="s3" style="padding-top: 7pt;padding-left: 27pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Flame  emission  spectroscopy  and    Atomic    absorption spectroscopy: <span class="p">Principle, Instrumentation, Interferences and Applications.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l2"><li data-list-text="2"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">NMR spectroscopy: Quantum numbers and their role in NMR, Principle, Instrumentation, Solvent requirement in NMR, Relaxation process, NMR signals in various compounds, Chemical shift, Factors influencing chemical  shift, Spin-Spin coupling, Coupling constant, Nuclear magnetic double resonance, Brief outline of principles of FT-NMR and 13C NMR. Applications of NMR spectroscopy.</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Mass Spectroscopy: <span class="p">Principle, Theory, Instrumentation of Mass Spectroscopy, Different types of ionization like electron impact, chemical, field, FAB and MALDI, APCI, ESI, APPI Analyzers of Quadrupole and Time of Flight, Mass fragmentation and its rules, Meta stable ions, Isotopic peaks and Applications of Mass spectroscopy</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Chromatography:  <span class="p">Principle,  apparatus,  instrumentation, chromatographic parameters, factors affecting resolution and applications of the following:</span></p><ol id="l3"><li data-list-text="a)"><p style="padding-left: 38pt;text-indent: -10pt;line-height: 10pt;text-align: left;">Paper chromatography b) Thin Layer chromatography</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">c) Ion exchange chromatography d) Column chromatography</p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: left;">e)  Gas  chromatography  f) High Performance Liquid chromatography</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">g) Affinity chromatography</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="5"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 88%;text-align: justify;">Electrophoresis: <span class="p">Principle, Instrumentation, Working conditions, factors affecting separation and applications of the following:</span></p><ol id="l4"><li data-list-text="a)"><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Paper electrophoresis b) Gel electrophoresis c) Capillary electrophoresis d) Zone electrophoresis e) Moving boundary electrophoresis f) Iso electric focusing</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">X ray Crystallography: <span class="p">Production of X rays, Different X ray methods, Bragg‘s law, Rotating crystal technique, X ray powder technique, Types of crystals and applications of X-ray diffraction.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: justify;">6. <span class="s3">Immunological Assays: </span>Radioimmunology assay (RIA), ELISA (Theory &amp; practical) and knowledge on Bioluminescence assays.</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l5"><li data-list-text="5"><p style="padding-left: 12pt;text-indent: -7pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 10pt;text-align: left;">REFERENCES</p><p style="padding-left: 12pt;text-indent: 0pt;line-height: 11pt;text-align: left;">1. Spectrometric Identification of Organic compounds - Robert M Silverstein,</p><p class="s4" style="padding-left: 31pt;text-indent: 0pt;line-height: 3pt;text-align: left;">th</p></li><li data-list-text="6"><p style="padding-left: 42pt;text-indent: -15pt;line-height: 9pt;text-align: left;">edition, John Wiley &amp; Sons, 2004.</p></li></ol></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 67%;text-align: left;">Principles of Instrumental Analysis - Doglas A Skoog, F. James Holler, Timothy A. Nieman, 5<span class="s5">th</span> edition, Eastern press , Bangalore, 1998.</p><p class="s4" style="padding-left: 118pt;text-indent: 0pt;line-height: 1pt;text-align: center;">t h</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 7pt;text-align: left;">Instrumental methods of analysis – Willards, 7 edition, CBS publishers.</p><p class="s4" style="text-indent: 0pt;line-height: 4pt;text-align: right;">th</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 72%;text-align: left;">Practical Pharmaceutical Chemistry – Beckett and Stenlake, Vol II, 4 edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 8pt;text-align: left;">Organic Spectroscopy - William Kemp, 3<span class="s5">rd</span> edition, ELBS, 1991.</p></li><li data-list-text="6."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 64%;text-align: left;">Quantitative Analysis of Drugs in Pharmaceutical formulation - P D Sethi, 3<span class="s6">rd </span>Edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="7."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 75%;text-align: left;">Pharmaceutical Analysis- Modern methods – Part B - J W Munson, Volume 11, Marcel Dekker Series</p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 44pt;text-indent: 0pt;line-height: 113%;text-align: center;">PHARMACEUTICAL FORMULATION DEVELOPMENT (MIP 102T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 88%;text-align: left;">This course is designed to impart knowledge and skills necessary to train the students on par with the routine of Industrial activities in R&amp;D and F&amp;D.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p class="s3" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: left;">On completion of this course it is expected that students will be able to understand-</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;text-align: left;">  The scheduled activities in a Pharmaceutical firm.</p><p class="s3" style="padding-top: 2pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">  The pre formulation studies of pilot batches of pharmaceutical industry.</p><p class="s3" style="padding-top: 2pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">  The significance of dissolution and product stability</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 12pt;text-indent: 0pt;text-align: center;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s3">Preformulation Studies: </span>Molecular optimization of APIs (drug substances), crystal morphology and variations, powder flow, structure modification, drug-excipient compatibility studies, methods of determination.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l6"><li data-list-text="2"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Formulation Additives<span class="p">: Study of different formulation additives, factors influencing their incorporation, role of formulation development and processing, new developments in excipient science. Design of experiments – factorial design for product and process development.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Solubility: <span class="p">Importance, experimental determination, phase- solubility analysis, pH-solubility profile, solubility techniques to improve solubility and utilization of analytical methods – cosolvency, salt formation, complexation, solid dispersion, micellar solubilization and hydrotropy.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Dissolution: <span class="p">Theories, mechanisms of dissolution, </span>in<span class="p">-</span>vitro <span class="p">dissolution testing models – sink and non-sink. Factors influencing dissolution and intrinsic dissolution studies. Dissolution test apparatus – designs, dissolution testing for conventional and controlled release products. Data handling and correction factor. Biorelevent media, </span>in<span class="p">-</span>vitro <span class="p">and </span>in<span class="p">-</span>vivo <span class="p">correlations, levels of correlations.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Product Stability: <span class="p">Degradation kinetics, mechanisms, stability testing of drugs and pharmaceuticals, factors influencing-media effects and pH effects, accelerated stability studies, interpretation of kinetic data (API &amp; tablets). Solid state stability and shelf life assignment. Stability protocols, reports and ICH guidelines.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l7"><li data-list-text="1."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Lachman L, Lieberman HA, Kanig JL. The Theory and Practice Of</p><p class="s4" style="padding-left: 31pt;text-indent: 0pt;line-height: 5pt;text-align: center;">rd</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Industrial Pharmacy, 3 ed., Varghese Publishers, Mumbai 1991.</p><p class="s4" style="text-indent: 0pt;line-height: 7pt;text-align: right;">th</p></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 76%;text-align: left;">Sinko PJ. Martin&#39;s physical pharmacy and pharmaceutical sciences, 5 ed., B.I. Publications Pvt. Ltd, Noida, 2006.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 8pt;text-align: left;">Lieberman HA, Lachman L, Schwartz JB. Pharmaceutical dosage forms:</p><p class="s4" style="padding-left: 96pt;text-indent: 0pt;line-height: 5pt;text-align: left;">nd</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: left;">tablets Vol. I-III, 2 ed., CBS Publishers &amp; distributors, New Delhi, 2005.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 74%;text-align: justify;">Conners KA. A Text book of pharmaceutical analysi Wells JI. Pharmaceutical preformulation: The physicochemical properties of drug substances. Ellis Horwood Ltd., England, 1998.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 75%;text-align: justify;">Yalkowsky SH. Techniques of solubilization of drugs. Vol-12. Marcel Dekker Inc., New York, 1981</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 78%;text-align: justify;">Dressman J, Kramer J. Pharmaceutical dissolution testing. Saurah printer pvt. Ltd., New Delhi,2005.</p><p class="s4" style="text-indent: 0pt;line-height: 3pt;text-align: right;">rd</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 79%;text-align: left;">Sethi PD. Quantitative analysis of drugs in pharmaceutical formulations, 3 ed., CBS publications, New Delhi, 2008.</p></li><li data-list-text="8."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 76%;text-align: left;">Carstensen JT, Rhodes CT. Drug stability principles and practices, 3 CBS Publishers &amp; distributors, New Delhi, 2005.</p><p class="s4" style="text-indent: 0pt;line-height: 4pt;text-align: left;">rd</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ed.,</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 78%;text-align: left;">Yoshioka S, Stella VJ. Stability of drugs and dosage forms, Springer (India) Pvt. Ltd., New Delhi, 2006.</p><p class="s4" style="text-indent: 0pt;line-height: 3pt;text-align: right;">th</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 75%;text-align: left;">Banker GS, Rhodes CT. Modern Pharmaceutics, 4 Inc, New York, 2005.</p></li><li data-list-text="11."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 10pt;text-align: left;">W. Grimm - Stability testing of drug products.</p><p style="padding-top: 2pt;text-indent: 0pt;text-align: left;">ed., Marcel Dekker</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Mazzo DJ. International stability testing. Eastern Press Pvt. Ltd.,</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Bangalore, 1999. 13. Beckett AH, Stenlake JB. Practical pharmaceutical</p><p class="s4" style="padding-left: 31pt;text-indent: 0pt;line-height: 6pt;text-align: center;">th</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 74%;text-align: left;">chemistry, Part I &amp; II., 4 2004.</p><p style="padding-left: 6pt;text-indent: 0pt;line-height: 11pt;text-align: left;">ed., CBS Publishers &amp; distributors, New Delhi,</p><ol id="l8"><li data-list-text="14."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Indian Pharmacopoeia. Controller of Publication. Delhi, 1996.</p></li><li data-list-text="15."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 75%;text-align: left;">British Pharmacopoeia. British Pharmacopoeia Commission Office, London, 2008.</p></li><li data-list-text="16."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 74%;text-align: left;">United States Pharmacopoeia. United States Pharmacopeial Convention, Inc, USA, 2003.</p></li><li data-list-text="17."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Encyclopaedia of Pharm. Technology, Vol I – III.</p></li><li data-list-text="18."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 75%;text-align: left;">Wells J. I. Pharmaceutical Preformulation : The physicochemical properties of drug substances, Ellis Horwood Ltd. England, 1988.</p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 140pt;text-indent: -60pt;line-height: 113%;text-align: left;">NOVEL DRUG DELIVERY SYSTEMS (MIP 103T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">This course is designed to impart knowledge and skills necessary to train the students in the area of novel drug delivery systems.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objective</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">On completion of this course it is expected that students will be able to understand,</p><p class="s3" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">The need, concept, design and evaluation of various customized, sustained and controlled release dosage forms.</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;text-align: left;">  <span class="p">To formulate and evaluate various novel drug delivery systems</span></p><p class="s3" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s3">Concept &amp; Models for NDDS: </span>Classification of rate controlled drug delivery systems (DDS), rate programmed release, activation modulated &amp; feedback regulated DDS, effect of system parameters in controlled drug delivery, computation of desired release rate and dose for controlled release DDS, pharmacokinetic design for DDS – intermittent, zero order &amp; first order release.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Carriers for  Drug  Delivery:    <span class="p">Polymers / co-polymers- introduction, classification, characterization, polymerization techniques, application in CDDS / NDDS, biodegradable &amp; natural polymers.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l9"><li data-list-text="2"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Study of Various DDS: <span class="p">Concepts, design, formulation &amp; evaluation of controlled release oral DDS, Mucoadhesive DDS (buccal, nasal, pulmonary) Pulsatile, colon specific, liquid sustained release systems, Ocular delivery systems</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Transdermal Drug Delivery Systems:  <span class="p">Theory,  design, formulation &amp; evaluation including iontophoresis and other latest developments in skin delivery systems.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 88%;text-align: justify;">Sub Micron Cosmeceuticals: <span class="p">Biology, formulation science and evaluation of various cosmetics for skin, hair, nail, eye etc and it’s regulatory aspects.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">08</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">04</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Targeted Drug Delivery Systems: <span class="p">Importance,  concept, biological process and events involved in drug targeting, design, formulation &amp; evaluation, methods in drug targeting – nanoparticles, liposomes, niosomes, pharmacosomes, resealed erythrocytes, microspheres, magnetic microspheres. Specialized pharmaceutical emulsions – multiple emulsions, micro-emulsions.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="6"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Protein / Peptide Drug Delivery Systems: <span class="p">Concepts, delivery techniques, formulation, stability testing, causes of protein destabilization, stabilization methods.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="7"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Biotechnology in Drug  Delivery Systems:  <span class="p">Brief review of major areas-recombinant DNA technology, monoclonal antibodies, gene therapy.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="8"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">New trends for Personalized Medicine: I<span class="p">ntroduction, Definition, Pharmacogenetics, Categories of Patients for Personalized Medicines: Customized drug delivery systems, Bioelectronic Medicines, 3D printing of pharmaceuticals, Telepharmacy.</span></p><p class="s3" style="padding-top: 8pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l10"><li data-list-text="1."><p style="padding-left: 25pt;text-indent: -12pt;text-align: left;">Novel Drug Delivery System, Y.W. Chein, Vol 50, Marcel Dekker, NY.</p><p style="padding-top: 1pt;padding-left: 1pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 1pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 1pt;text-indent: 0pt;line-height: 13pt;text-align: left;">06</p><p style="padding-left: 1pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 7pt;padding-left: 1pt;text-indent: 0pt;line-height: 13pt;text-align: left;">06</p><p style="padding-left: 1pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="2."><p style="padding-left: 25pt;text-indent: -12pt;line-height: 12pt;text-align: left;">Controlled Drug Delivery Systems, Robinson, Vol 29, Marcel Dekker, NY.</p></li><li data-list-text="3."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Transdermal Controlled Systemic Medications, YW Chein, Vol 31, Marcel Dekker, NY.</p></li><li data-list-text="4."><p style="padding-left: 25pt;text-indent: -12pt;line-height: 11pt;text-align: left;">Bioadhesive DDS, E. Mathiowitz, Vol 98, Marcel Dekker, NY.</p></li><li data-list-text="5."><p style="padding-left: 25pt;text-indent: -12pt;line-height: 12pt;text-align: left;">Nasal System Drug Delivery, K.S.E. Su, Vol 39, Marcel Dekker, NY.</p></li><li data-list-text="6."><p style="padding-left: 25pt;text-indent: -12pt;line-height: 12pt;text-align: left;">Drug Delivery Devices, Vol 32, P Tyle Marcel Dekker, NY.</p></li><li data-list-text="7."><p style="padding-left: 25pt;text-indent: -12pt;line-height: 12pt;text-align: left;">Polymers for Controlled Drug Delivery, P.J. Tarcha, CRC Press.</p></li><li data-list-text="8."><p style="padding-left: 25pt;text-indent: -12pt;line-height: 13pt;text-align: left;">Pharmaceutical Biotechnology, Vyas, CBS, Delhi.</p></li><li data-list-text="9."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Biotechnology of Industrial Antibiotics, E.J. Vandamme, Marcel Dekker, NY.</p></li><li data-list-text="10."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Protein Formulation &amp; Delivery, E.J. McNally, Vol 99, Marcel Dekker, NY.</p></li><li data-list-text="11."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Drug Targeting, M.H. Rubinstein, John Wiley, NY.</p></li></ol></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 140pt;text-indent: -61pt;line-height: 113%;text-align: left;">INTELLECTUAL PROPERTY RIGHTS (MIP 104T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: justify;">This course is designed to impart knowledge and skills necessary to train the students to be on par with the routine of Industrial activities in drug regulatory affairs</p><p class="s3" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: left;">On completion of this course it is expected that students will be able to understand,</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Assist in Regulatory Audit process.</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Establish regulatory guidelines for drug and drug products</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">The Regulatory requirements for contract research organization</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                              60 Hrs</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">1.  Definition, Need for patenting, Types of Patents, Conditions to be satisfied by an invention to be patentable, Introduction to patent search. Parts of patents. Filling of patents. The essential elements of patent; Guidelines for preparation of laboratory note book, Non-obviousness in Patent.</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">12 Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2  Role of GATT, TRIPS, and WIPO              12 Hrs</p><p style="padding-top: 6pt;padding-left: 27pt;text-indent: -22pt;line-height: 79%;text-align: left;">3  Brief introduction to Trademark protection and WHO Patents. IPR’s and its types, Major bodies regulating Indian Pharmaceutical sector.</p><p style="padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: left;">4  Brief introduction to CDSCO. WHO, USFDA, EMEA, TGA, MHRA, MCC, ANVISA</p><p style="padding-left: 27pt;text-indent: -22pt;line-height: 84%;text-align: left;">5  Regulatory requirements for contract research organization. Regulations for Biosimilars.</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">12 Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">12 Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">12 Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES :</p><ol id="l11"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 19pt;text-indent: -13pt;line-height: 85%;text-align: left;">Pharmaceutical Process Validation: By Fra R. Berry and Robert A. Nash, Vol 57, 2<span class="s7">nd </span>Edition</p></li><li data-list-text="2."><p style="padding-left: 19pt;text-indent: -11pt;line-height: 85%;text-align: left;">Applied Production and Operation Management By Evans, Anderson and Williams</p></li><li data-list-text="3."><p style="padding-left: 20pt;text-indent: -12pt;line-height: 86%;text-align: left;">GMP for pharmaceuticals Material Management by K.K. Ahuja Published by CBS publishers</p></li><li data-list-text="4."><p style="padding-left: 20pt;text-indent: -12pt;line-height: 11pt;text-align: left;">ISO 9000-Norms and explanations</p></li><li data-list-text="5."><p style="padding-left: 18pt;text-indent: -10pt;line-height: 13pt;text-align: left;">GMP for pharmaceuticals- Willing S.H. Marcel and Dekker</p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 143pt;text-indent: -71pt;line-height: 113%;text-align: left;">INDUSTRIAL PHARMACY PRACTICAL - I (MIP 105P)</p><ol id="l12"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 19pt;text-indent: -13pt;line-height: 85%;text-align: left;">Analysis of pharmacopoeial compounds and their formulations by UV Vis spectrophotometer</p></li><li data-list-text="2."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 9pt;text-align: left;">Simultaneous estimation of multi component containing formulations by UV</p><p style="padding-left: 19pt;text-indent: 0pt;line-height: 12pt;text-align: left;">spectrophotometry</p></li><li data-list-text="3."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Experiments based on HPLC / GC</p></li><li data-list-text="4."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Estimation of riboflavin/quinine sulphate by fluorimetry</p></li><li data-list-text="5."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Estimation of sodium/potassium by flame photometry</p></li><li data-list-text="6."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Effect of surfactants on the solubility of drugs.</p></li><li data-list-text="7."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 11pt;text-align: left;">Effect of pH on the solubility of drugs.</p></li><li data-list-text="8."><p style="padding-left: 19pt;text-indent: -13pt;line-height: 10pt;text-align: left;">Stability testing of solution and solid dosage forms for photo degradation..</p><p class="s4" style="padding-left: 210pt;text-indent: 0pt;line-height: 7pt;text-align: left;">o           o</p></li><li data-list-text="9."><p style="padding-top: 5pt;padding-left: 19pt;text-indent: -13pt;line-height: 70%;text-align: left;">Stability studies of drugs in dosage forms at 25 RH.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">C, 60% RH and 40 C, 75%</p></li><li data-list-text="10."><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: left;">Compatibility evaluation of drugs and excipients (DSC &amp; FTIR). 11.Preparation and evaluation of different polymeric membranes. 12.Formulation and evaluation of sustained release oral matrix tablet/ oral</p></li></ol><p style="padding-left: 19pt;text-indent: 0pt;line-height: 11pt;text-align: left;">reservoir system.</p></li><li data-list-text="13."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">Formulation and evaluation of microspheres / microcapsules. 14.Formulation and evaluation of transdermal drug delivery systems.</p></li></ol></li></ol><ol id="l13"><li data-list-text="15."><p style="padding-top: 1pt;padding-left: 19pt;text-indent: -13pt;line-height: 86%;text-align: left;">Design and evaluation of face wash, body- wash, creams, lotions, shampoo, toothpaste, lipstick.</p></li><li data-list-text="16."><p style="padding-left: 18pt;text-indent: -13pt;line-height: 11pt;text-align: left;">Electrophoresis of protein solution.</p></li><li data-list-text="17."><p style="padding-left: 18pt;text-indent: -13pt;line-height: 13pt;text-align: left;">Preparation and evaluation of Liposome delivery system.</p></li></ol></body></html>
